Jing Li

5PUBLICATIONS
1CO-AUTHORS
Molecular targetsInnate immunityMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 30, 2026
AKR1C3-PKM2-oxidative phosphorylation axis drives prostate cancer radioresistance via UBE2T upregulation.

Jinyu Zhang, Jiongzheng Li, Yufei Yan

|Sep 06, 2024
Ocotillol-Type Pseudoginsenoside-F11 Alleviates Lipopolysaccharide-Induced Acute Kidney Injury through Regulation of Macrophage Function by Suppressing the NF-κB/NLRP3/IL-1β Signaling Pathway.

Yaru Wang, Jinyu Zhang, Zhuo Yang

|Mar 25, 2024
Pyxinol Fatty Acid Ester Derivatives J16 against AKI by Selectively Promoting M1 Transition to M2c Macrophages.

Yaru Wang, Changcheng Li, Jingyi Chen

|Mar 11, 2023
Establishing a Proteomics-Based Signature of AKR1C3-Related Genes for Predicting the Prognosis of Prostate Cancer.

Xiaoli Cui, Changcheng Li, Jipeng Ding

|Jan 19, 2023
When type II diabetes mellitus meets COVID-19-Identification of the shared gene signatures and biological mechanism between the two diseases.

Tianyu Zhao, JiPeng Ding, Zuowen Liang

Pageof 1

Frequent Collaborators

2 joint publications

Jinping Liu